Reporting Manager
Longitude Capital Partners V, LLC
Symbol
CTMX
Shares outstanding
158,061,110 shares
Disclosed Ownership
11,538,461 shares
Ownership
7.3%
Form type
SCHEDULE 13G
Filing time
20 May 2025, 21:00:40 UTC
Date of event
13 May 2025
Next filing
15 May 2026

Key filing fact

Longitude Capital Partners V, LLC disclosed 7.3% ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX) on 13 May 2025.

Key facts

  • Longitude Capital Partners V, LLC filed SCHEDULE 13G for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX).
  • Disclosed ownership: 7.3%.
  • Date of event: 13 May 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 20 May 2025, 21:00.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Longitude Capital Partners V, LLC 7.3% 11,538,461 0 11,538,461 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory
Longitude Venture Partners V, L.P. 7.3% 11,538,461 0 11,538,461 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, Authorized Signatory
Patrick G. Enright 7.3% 11,538,461 0 11,538,461 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Juliet Tammenoms Bakker 7.3% 11,538,461 0 11,538,461 /s/ Cristiana Blauth Oliveira Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .